MW Gestion v. Global Cord Blood Corporation et al: Class Action Complaint (‘Securities Fraud’)

    Class Action Complaint in MW Gestion, described as “an institutional asset manager based in France” v. Global Cord Blood Corporation, described as a Cayman Islands-domiciled, Hong Kong-based company that “provides umbilical cord blood storage and ancillary services in the in the Beijing Municipality, Guangdong Province, and Zhejiang Province of the People’s Republic of China”; Ting Zheng, Bing Chuen, a.k.a. Albert Chen; Yuen Kam, Mark Da-Jian Chen, Jennifer J. Weng, Ken Lu, Jack Chow, Jacky Cheng, Golden Meditech Holdings Limited, of the Cayman Islands; Golden Meditech Stem Cells (BVI) Company Limited, of the British Virgin Islands; GM Precision Medicine (BVI) Limited, of the British Virgin Islands; Golden Meditech Precision Medicine Limited, of Hong Kong; Golden Meditech (BVI) Company Limited, of the British Virgin Islands, and KPMG Huazhen LLP at the U.S. District Court for the Southern District of New York.


  • 56
    April 22, 2024
    Global Cord Blood Corporation, Ting Zheng, Bing Chuen (Albert) Chen, Yuen Kam, Mark Da-Jian Chen, Jennifer J. Weng, Ken Lu, Jack Chow, Jacky Cheng, Golden Meditech Holdings Limited, Golden Meditech Stem Cells (BVI) Company Limited, GM Precision Medicine (BVI) Limited, Golden Meditech Precision Medicine Limited, Golden Meditech (BVI) Company Limited, KPMG Huazhen LLP
    MW Gestion
    Xx Xx Xx
    Fraud
    Pomerantz, Michael Grunfeld